 Connection
Albaha Barqawi to Prostate-Specific Antigen
This is a "connection" page, showing publications Albaha Barqawi has written about Prostate-Specific Antigen.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.318 |
|
|
|
-
Barqawi A, Pessoa RR, Al-Musawi M, MacDermott T, O'Donnell CI. The Impact of Performing a 3D Mapping Biopsy Prior to Primary Cryotherapy for the Treatment of Prostate Cancer. Urology. 2020 10; 144:171-176.
Score: 0.161
-
Flaig TW, Barqawi A, Miller G, Kane M, Zeng C, Crawford ED, Glod? LM. A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer. Cancer. 2006 Jul 15; 107(2):266-74.
Score: 0.061
-
Crawford ED, Barqawi A. Intermediate- to high-risk prostate cancer patient treated with radiation therapy. Oncology (Williston Park). 2004 Aug; 18(9):1105-10.
Score: 0.053
-
Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi A, Crighton F, Glod? LM. Prostate cancer in a man with multiple previous cancers. Oncology (Williston Park). 2007 Apr; 21(5):611-4.
Score: 0.016
-
Ziada A, Barqawi A, Glode LM, Varella-Garcia M, Crighton F, Majeski S, Rosenblum M, Kane M, Chen L, Crawford ED. The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. Prostate. 2004 Sep 01; 60(4):332-7.
Score: 0.013
-
Glode LM, Barqawi A, Crighton F, Crawford ED, Kerbel R. Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma. Cancer. 2003 Oct 15; 98(8):1643-8.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|